A Study of LY2835219 in Participants With Cancer

Clinical trial NCT02117648 · COMPLETED

Trial details

NCT number: NCT02117648
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Neoplasm Metastasis

Start date: 2014-04-01
Primary completion: 2015-02-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.